CHRONIC INTERACTION BETWEEN METFORMIN AND MELOXICAM IN MICE

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 2

Abstract

Objective: This study is performed for investigation the chronic interaction between metformin and meloxicam from toxicological view. Methods: Lethal dose 50 after chronic exposure assessed in mice by up and down method. Their interaction analyzed by isobolographic analysis indicated that both medicines exhibited synergism. Assessment of the effects of repeated chronic dosing for 3 months of both medicines also performed on mice. Medicines in question administered orally as therapeutic doses of metformin 14 mg/kg. Body weight (BW) (G1), meloxicam 0.2 mg/kg.BW (G2), and combination of both medicines (G3) while G4 assigned control and dosed DW. Results: Both G1 and G3 showed significant p˂0.05 decrease in blood glucose and serum cholesterol levels. Meloxicam group (G3) showed statistically significant p˂0.05 increase in triglycerides and alanine aminotransferase (ALT), and aspartate aminotransferase (AST), while group of combination showed statistically significant p≤0.05 decrease in both ALT and AST. Blood urea nitrogen, uric acid, and serum creatinine showed statistically significant p˂0.05 increase in group of meloxicam but decrease in G3 and no changes in G1. Histopathological changes included variable lesions in kidney such as swelling and necrosis in renal tubules of metformin group, cortical vacuolar degeneration in renal tubules, and deterioration of most glomeruli in G2, while G3 showed generalized cortical necrosis of renal tubules and interstitial nephritis. Liver lesions included central venous congestion (VC) and perivascular lymphocytic infiltration and marked necrosis in both groups of metformin and meloxicam, while there were severe VC and necrosis of hepatocytes in group of combination. Conclusion: Metformin administration with meloxicam may have beneficial important through preventing many deleterious effects of meloxicam after long-standing administration, but adjusting dosing regimen study might be recommended.

Authors and Affiliations

FALAH MUOSA KADHIM AL-REKABI

Keywords

Related Articles

QUANTITATIVE DETERMINATION OF CRIZOTINIB IN HUMAN PLASMA WITH HIGHPERFORMANCE LIQUID CHROMATOGRAPHY AND ULTRAVIOLET DETECTION

Objective: A rapid, sensitive, selective, and reproducible reversed-phase high-performance liquid chromatographic method has been developed and validated for the determination of crizotinib (CRZ), a tyrosine kinase inhib...

SURVEY, ISOLATION, BIOCHEMICAL CHARACTERIZATION, AND IDENTIFICATION OF HELICOBACTER PYLORI FROM GASTRIC PATIENT BIOPSY

Objective: This study was to isolate and identify the Helicobacter pylori from the biopsy samples of the gastric patient.Methods: Gastric biopsies were collected from the antral region of the gastric patient. Out of 96 p...

IN VITRO FREE RADICAL SCAVENGING ACTIVITY AND IN VIVO ANTICATARACT POTENTIAL OF HEMIDESMUS INDICUS ROOTS IN STREPTOZOTOCIN INDUCED DIABETIC RATS

Objective: Hemidesmus indicus R. Br. (HI) (Indian sarsaparilla) is traditionally used in Indian medicine for human therapy. The present study was aimed to evaluate the antioxidant activity of HI root extracts, and its ef...

RATE OF MALIGNANT BREAST CANCER AMONG WOMEN WITH BREAST MASS ATTENDING ALDEWANIYAH TEACHING HOSPITALS: A CROSS-SECTIONAL STUDY

Objective: The problems of breast mass, pain, or discharge are extremely common in the Iraqi population, as well as, globally. However, the trend in most health-care institutions is that most breast lesions are of benign...

A RECENT UPDATE: ANTIMICROBIAL AGENTS CONTAINING PYRAZOLE NUCLEUS

Objective: In this review, we report antimicrobial candidates containing pyrazole nucleus integrated with various functionalities.Methods: research results by numerous scientists have been summarized from international j...

Download PDF file
  • EP ID EP608810
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

FALAH MUOSA KADHIM AL-REKABI (2019). CHRONIC INTERACTION BETWEEN METFORMIN AND MELOXICAM IN MICE. Asian Journal of Pharamceutical and Clinical Research, 12(2), 452-458. https://europub.co.uk/articles/-A-608810